Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 1
1998 2
1999 1
2001 1
2002 1
2004 1
2005 1
2007 5
2008 3
2009 3
2010 6
2011 6
2012 9
2013 8
2014 9
2015 7
2016 6
2017 9
2018 10
2019 5
2020 7
2021 12
2022 14
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, Shindo H, Teshima M, Horiguchi K, Yoshida Y, Kanai T, Hirokawa M, Hames KY, Tabei I, Miyauchi A. Sugitani I, et al. Thyroid. 2021 Feb;31(2):183-192. doi: 10.1089/thy.2020.0330. Epub 2020 Nov 2. Thyroid. 2021. PMID: 33023426 Free PMC article. Review.
Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).
Higashiyama T, Sugino K, Hara H, Ito KI, Nakashima N, Onoda N, Tori M, Katoh H, Kiyota N, Ota I, Suganuma N, Hibi Y, Nemoto T, Takahashi S, Yane K, Ioji T, Kojima S, Kaneda H, Sugitani I, Tahara M. Higashiyama T, et al. Among authors: sugitani i. Eur J Cancer. 2022 Sep;173:210-218. doi: 10.1016/j.ejca.2022.06.044. Epub 2022 Aug 3. Eur J Cancer. 2022. PMID: 35932627 Clinical Trial.
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI).
Brose MS, Smit JWA, Lin CC, Tori M, Bowles DW, Worden F, Shen DH, Huang SM, Tsai HJ, Alevizaki M, Peeters RP, Takahashi S, Rumyantsev P, Guan R, Babajanyan S, Ozgurdal K, Sugitani I, Pitoia F, Lamartina L. Brose MS, et al. Among authors: sugitani i. Thyroid. 2022 Sep;32(9):1059-1068. doi: 10.1089/thy.2022.0061. Thyroid. 2022. PMID: 35950621 Clinical Trial.
Non-functioning oxyphilic parathyroid carcinoma: a case report.
Sen M, Nagaoka R, Kazusaka H, Matsui M, Saitou M, Sugitani I, Sakatani T, Kameyama K. Sen M, et al. Among authors: sugitani i. Surg Case Rep. 2021 May 12;7(1):119. doi: 10.1186/s40792-021-01201-y. Surg Case Rep. 2021. PMID: 33978837 Free PMC article.
Anesthetic Considerations of Intraoperative Neuromonitoring in Thyroidectomy.
Namizato D, Iwasaki M, Ishikawa M, Nagaoka R, Genda Y, Kishikawa H, Sugitani I, Sakamoto A. Namizato D, et al. Among authors: sugitani i. J Nippon Med Sch. 2019 Dec 3;86(5):263-268. doi: 10.1272/jnms.JNMS.2019_86-408. Epub 2019 May 17. J Nippon Med Sch. 2019. PMID: 31105118 Free article.
Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
Sakai T, Sugitani I, Ebina A, Fukuoka O, Toda K, Mitani H, Yamada K. Sakai T, et al. Among authors: sugitani i. Thyroid. 2019 Jan;29(1):59-63. doi: 10.1089/thy.2018.0462. Epub 2019 Jan 8. Thyroid. 2019. PMID: 30560718
116 results